Nandrolone Decanoate
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | IM | 1-5 mg/kg | Every 2-3 weeks | Duration: Up to 3-6 months depending on response Notes: Use lower end for cats; monitor liver function and signs of virilization. |
| Cat | IM | 1-2 mg/kg | Every 2-3 weeks | Duration: Up to 3 months Notes: May stimulate appetite in chronic renal failure. |
| Horse | IM | 0.5-1 mg/kg | Every 3-4 weeks | Duration: Variable; often used for 3-6 months Notes: Check competition rules; withdrawal times may apply. |
| Cattle | IM | 0.5-1 mg/kg | Every 3-4 weeks | Duration: Short-term only Notes: Extra-label use; not approved for growth promotion in many regions. |
| Small Ruminants | IM | 0.5-1 mg/kg | Every 3-4 weeks | Duration: Short-term Notes: Limited data; use with caution. |
| Rabbit | IM | 1-2 mg/kg | Every 2-3 weeks | Duration: Short-term Notes: Limited data; use with caution. |
Clinical Indications & Species Uses
- Anabolic steroid for supportive therapy in chronic wasting conditions, anemia, and convalescence
- Anabolic support in chronic wasting conditions
- Convalescence after surgery or illness
- Fracture healing
- Anemia (especially non-regenerative)
- Muscle wasting due to chronic disease
- Anabolic support in chronic renal failure (to stimulate appetite and improve muscle mass)
- Wasting syndromes
- Non-regenerative anemia
- Anabolic support in debilitated horses
- Convalescence
- Muscle development in performance horses (though controversial and often prohibited in competition)
- May be used in debilitated animals under extra-label conditions
Pharmacology & Mechanism of Action
Drug Class: Anabolic steroid | Pharmacological Group: Androgen/anabolic steroid (AAS)
Mechanism of Action: Nandrolone decanoate is a synthetic derivative of testosterone with enhanced anabolic activity and reduced androgenic effects. It binds to androgen receptors in target tissues, leading to increased protein synthesis, nitrogen retention, and muscle mass. It also stimulates erythropoietin release, increasing red blood cell production. The decanoate ester prolongs the duration of action by slow release from the injection site.
Pharmacodynamics: Nandrolone promotes positive nitrogen balance, increases appetite, and improves weight gain. It has a high anabolic-to-androgenic ratio (approximately 10:1). It also has anti-catabolic effects, reducing muscle breakdown during illness or stress. In bone marrow, it stimulates erythropoiesis. It may also have beneficial effects on calcium metabolism and bone density.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Pregnancy (may cause virilization of female fetus)
- Lactation (excreted in milk)
- Known hypersensitivity to nandrolone or other anabolic steroids
- Prostatic carcinoma or mammary carcinoma (androgen-dependent tumors)
- Hypercalcemia (may worsen)
- Severe hepatic or renal disease (use with caution)
- Cardiac disease (may cause fluid retention)
- Use with caution in animals with pre-existing cardiac, renal, or hepatic disease.
- May cause sodium and water retention, leading to edema.
- May suppress endogenous testosterone production; long-term use may cause testicular atrophy.
- In food animals, observe withdrawal times; extra-label use is regulated.
- In performance animals, check for prohibited substances.
- Use in young, growing animals may cause premature epiphyseal closure.
- May cause aggressive behavior or increased libido.
Adverse Effects & Reactions
Common:
- Injection site pain or swelling
- Increased aggression
- Increased libido
- Mild fluid retention
- Changes in liver enzymes
Serious / Severe:
- Hepatotoxicity (with prolonged use)
- Cardiac hypertrophy
- Prostatic hypertrophy
- Virilization in females (clitoral enlargement, deepening voice)
- Suppression of endogenous testosterone
- Premature epiphyseal closure in young animals
Rare:
- Cholestatic jaundice
- Peliosis hepatis
- Hepatic neoplasia (with long-term use)
- Hypercalcemia
- Erythrocytosis (polycythemia)
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Anticoagulants (e.g., warfarin) | May increase anticoagulant effect; monitor coagulation parameters. | Moderate |
| Corticosteroids | May increase risk of edema and hyperglycemia. | Moderate |
| Insulin or oral hypoglycemics | May alter glucose tolerance; adjust doses as needed. | Moderate |
| Hepatotoxic drugs (e.g., NSAIDs, azoles) | Increased risk of hepatotoxicity. | High |
| Thyroid hormones | May increase thyroid hormone levels; monitor thyroid function. | Mild |
Overdose & Toxicity Management
Signs of Toxicity:
- Edema
- Hepatotoxicity
- Aggression
- Hypercalcemia
- Polycythemia
- Virilization
- Premature epiphyseal closure in young animals
Emergency Treatment Protocol: Treatment is symptomatic and supportive. Discontinue the drug. Manage fluid retention with diuretics if necessary. Monitor liver function and serum calcium. In severe cases, consider supportive care such as IV fluids and hepatoprotectants. There is no specific antidote.
Food Animal Withdrawal Times
Withdrawal times are not officially established for nandrolone decanoate in food animals. Extra-label use requires extended withdrawal periods; consult with a veterinarian and follow regulatory guidelines. In the US, the FDA has not approved nandrolone for food animals, so use is prohibited in food animals unless under specific extra-label conditions with a valid VCPR and extended withdrawal times.
Storage, Handling & Regulatory Information
Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), excursions permitted between 15-30°C (59-86°F).
Handling & Special Conditions: Protect from freezing. Keep in tight container. Store away from direct heat.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Not FDA-approved for veterinary use; available as a human pharmaceutical (Deca-Durabolin) and may be used extra-label in animals.
Extra-Label (Off-Label) Use: In the US, nandrolone decanoate is not approved for veterinary use in food animals. Extra-label use in food animals is prohibited under AMDUCA because it is not approved for food animals and there is no established tolerance. In non-food animals, extra-label use is allowed under a valid VCPR. In horses, use may be prohibited in competition; check with regulatory bodies.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)